Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus
Frontiers in Bioengineering and Biotechnology · 23.10.2024 · 12
DOI: 10.3389/fbioe.2024.1455385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 23.10.2024. Verfasst von Zahra Chegini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Biofilms are bacterial communities that can protect them against external factors, including antibiotics. In this study, silver nanoparticles (AgNPs) were formed by modifying AgNPs with C-phycocyanin (Ag-Pc) to inhibit the growth of carbapenem-resistant Pseudomonas aeruginosa (CR P. aeruginosa ) and methicillin-resistant Staphylococcus aureus (MRSA) and destroy biofilm of these bacteria.
Methods
The AgNPs were prepared with the green synthesis method, and Pc was used to stabilize the AgNPs. The Ag-Pc’s antibacterial and antibiofilm effects were evaluated using the Microbroth dilution method and microtiter plate assay. The inhibitory effect of Ag-Pc on the expression of biofilm-related genes was evaluated by real-time PCR. Moreover, the MTT assay was used to assess the Ag-Pc toxicity.
Results
The Ag-Pc minimum inhibitory concentration (MIC) was 7.4 μg/mL for CR P. aeruginosa and MRSA. Pc did not show antibacterial effects against any of the strains. Ag-Pc suppressed biofilm formation and destroyed matured biofilm in both bacteria more efficiently than the AgNPs (P< 0.05). The expression of all genes was not significantly reduced in the presence of synthesized nanoparticles. Finally, the MTT assay results did not show toxicity against a murine fibroblast cell line (L929) at MIC concentration.
Conclusion
The present study showed the promising potential of Pc for improving the antibacterial and antibiofilm function of AgNPs and inhibiting drug-resistant bacteria. Therefore, Ag-Pc nanoparticles can be considered a promising therapeutic approach for the managing of the bacterial biofilm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Infectious Diseases Research Center (IDRC), Arak University of medical sciences, Arak, Iran.
- Department of Organic Chemistry, Faculty of Chemistry and Petroleum Sciences, Bu-Ali Sina University, Hamedan, Iran.
- ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran.
- Infectious Diseases Research Centre, Hamadan University of Medical Sciences, Hamadan, Iran.
- Department of Tissue Engineering and Regenerative Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Zitieren
APA
Chegini, Z., Shariati, A., Alikhani, M. Y., Safaiee, M., Rajaeih, S., Arabestani, M., & Azizi, M. (2024). Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1455385
Vancouver
Chegini Z, Shariati A, Alikhani MY, Safaiee M, Rajaeih S, Arabestani M, et al. Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1455385
BibTeX
@article{Chegini2024,
author = {Chegini, Zahra and Shariati, Aref and Alikhani, Mohammad Yousef and Safaiee, Maliheh and Rajaeih, Shahin and Arabestani, Mohammadreza and Azizi, Mehdi},
title = {Antibacterial and antibiofilm activity of silver nanoparticles stabilized with C-phycocyanin against drug-resistant Pseudomonas aeruginosa and Staphylococcus aureus},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1455385}
}
EUVIMED